These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 26026740

  • 1. Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin.
    Stojković S, Podolski-Renić A, Dinić J, Stanković T, Banković J, Hadžić S, Paunović V, Isaković A, Tanić N, Pešić M.
    Exp Cell Res; 2015 Jul 15; 335(2):248-57. PubMed ID: 26026740
    [Abstract] [Full Text] [Related]

  • 2. Resistance to DNA Damaging Agents Produced Invasive Phenotype of Rat Glioma Cells-Characterization of a New in Vivo Model.
    Stojković S, Podolski-Renić A, Dinić J, Pavković Ž, Ayuso JM, Fernández LJ, Ochoa I, Pérez-García VM, Pešić V, Pešić M.
    Molecules; 2016 Jun 27; 21(7):. PubMed ID: 27355941
    [Abstract] [Full Text] [Related]

  • 3. Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1.
    Yang DI, Chen SD, Yang YT, Ju TC, Xu JM, Hsu CY.
    Br J Pharmacol; 2004 Mar 27; 141(6):988-96. PubMed ID: 14980978
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
    Yin JH, Yang DI, Chou H, Thompson EM, Xu J, Hsu CY.
    J Pharmacol Exp Ther; 2001 Apr 27; 297(1):308-15. PubMed ID: 11259558
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Daunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas.
    Kaaijk P, Troost D, de Boer OJ, Van Amstel P, Bakker PJ, Leenstra S, Bosch DA.
    Br J Cancer; 1996 Jul 27; 74(2):187-93. PubMed ID: 8688320
    [Abstract] [Full Text] [Related]

  • 13. The apurinic/apyrimidinic endonuclease activity of Ape1/Ref-1 contributes to human glioma cell resistance to alkylating agents and is elevated by oxidative stress.
    Silber JR, Bobola MS, Blank A, Schoeler KD, Haroldson PD, Huynh MB, Kolstoe DD.
    Clin Cancer Res; 2002 Sep 27; 8(9):3008-18. PubMed ID: 12231548
    [Abstract] [Full Text] [Related]

  • 14. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
    Yu Z, Xie G, Zhou G, Cheng Y, Zhang G, Yao G, Chen Y, Li Y, Zhao G.
    Cancer Lett; 2015 Oct 10; 367(1):58-68. PubMed ID: 26188279
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Acquisition of chemoresistance in gliomas is associated with increased mitochondrial coupling and decreased ROS production.
    Oliva CR, Moellering DR, Gillespie GY, Griguer CE.
    PLoS One; 2011 Oct 10; 6(9):e24665. PubMed ID: 21931801
    [Abstract] [Full Text] [Related]

  • 19. Pro-apoptotic role of integrin β3 in glioma cells.
    Kim JH, Zheng LT, Lee WH, Suk K.
    J Neurochem; 2011 May 10; 117(3):494-503. PubMed ID: 21332719
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.